Capitolis Liquid Global Markets’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.3M Buy
620,177
+512,166
+474% +$46.7M 0.24% 77
2026
Q1
$11.1M Buy
+108,011
New +$12.2M 0.07% 172
2025
Q3
Sell
-44,000
Closed -$5.98M 238
2025
Q2
$5.98M Sell
44,000
-135,000
-75% -$17.8M 0.04% 187
2025
Q1
$23.7M Hold
179,000
0.21% 75
2024
Q4
$20.2M Sell
179,000
-321,000
-64% -$37.1M 0.2% 62
2024
Q3
$57M Sell
500,000
-200,000
-29% -$21.9M 0.6% 40
2024
Q2
$72.7M Buy
+700,000
New +$74.2M 0.9% 33

Other funds holding ABT

Capitolis Liquid Global Markets's ABT Position: Q2 2026 in Review

Capitolis Liquid Global Markets increased its Abbott (ABT) stake by 474% in Q2 2026, buying an estimated $46.7M and bringing the position to 620,177 shares worth $56.3M. The position accounts for 0.24% of the portfolio, ranked #77.

Capitolis Liquid Global Markets first reported a position in ABT in Q2 2024 and has held it in 7 quarters since. The position peaked at $72.7M in Q2 2024. 2,967 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Capitolis Liquid Global Markets held 620,177 shares of Abbott worth $56.3M as of Q2 2026.
  • Capitolis Liquid Global Markets bought 512,166 Abbott shares in Q2 2026, an estimated $46.7M.
  • Abbott made up 0.24% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #77 holding.
  • Capitolis Liquid Global Markets first reported a position in Abbott in Q2 2024 and has held it in 7 quarters since.
  • Capitolis Liquid Global Markets's Abbott position peaked at $72.7M in Q2 2024.
  • 2,967 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.